WST vs. DHR
Compare and contrast key facts about West Pharmaceutical Services, Inc. (WST) and Danaher Corporation (DHR).
Performance
WST vs. DHR - Performance Comparison
Loading graphics...
WST vs. DHR - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
WST West Pharmaceutical Services, Inc. | -8.82% | -15.73% | -6.75% | 49.97% | -49.70% | 65.88% | 89.05% | 54.13% | -0.08% | 17.02% |
DHR Danaher Corporation | -17.00% | 0.35% | -0.35% | -1.22% | -19.02% | 48.57% | 45.34% | 49.55% | 11.80% | 20.01% |
Fundamentals
WST:
$18.22B
DHR:
$134.81B
WST:
$6.79
DHR:
$5.06
WST:
36.93
DHR:
37.49
WST:
5.93
DHR:
5.51
WST:
5.74
DHR:
2.57
WST:
$3.07B
DHR:
$24.57B
WST:
$1.10B
DHR:
$14.97B
WST:
$723.60M
DHR:
$7.02B
Returns By Period
In the year-to-date period, WST achieves a -8.82% return, which is significantly higher than DHR's -17.00% return. Over the past 10 years, WST has outperformed DHR with an annualized return of 13.95%, while DHR has yielded a comparatively lower 12.00% annualized return.
WST
- 1D
- 2.24%
- 1M
- -1.45%
- YTD
- -8.82%
- 6M
- -4.29%
- 1Y
- 12.35%
- 3Y*
- -9.99%
- 5Y*
- -2.27%
- 10Y*
- 13.95%
DHR
- 1D
- 3.11%
- 1M
- -9.80%
- YTD
- -17.00%
- 6M
- -4.03%
- 1Y
- -6.87%
- 3Y*
- -4.81%
- 5Y*
- -0.55%
- 10Y*
- 12.00%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
WST vs. DHR — Risk / Return Rank
WST
DHR
WST vs. DHR - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for West Pharmaceutical Services, Inc. (WST) and Danaher Corporation (DHR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| WST | DHR | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.30 | -0.21 | +0.51 |
Sortino ratioReturn per unit of downside risk | 0.83 | -0.09 | +0.92 |
Omega ratioGain probability vs. loss probability | 1.10 | 0.99 | +0.11 |
Calmar ratioReturn relative to maximum drawdown | 0.53 | -0.29 | +0.83 |
Martin ratioReturn relative to average drawdown | 1.10 | -0.87 | +1.97 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| WST | DHR | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.30 | -0.21 | +0.51 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.06 | -0.02 | -0.04 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.41 | 0.48 | -0.07 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.37 | 0.65 | -0.28 |
Correlation
The correlation between WST and DHR is 0.35, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
WST vs. DHR - Dividend Comparison
WST's dividend yield for the trailing twelve months is around 0.34%, less than DHR's 0.72% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
WST West Pharmaceutical Services, Inc. | 0.34% | 0.31% | 0.25% | 0.22% | 0.31% | 0.15% | 0.23% | 0.41% | 0.58% | 0.54% | 0.58% | 0.75% |
DHR Danaher Corporation | 0.72% | 0.56% | 0.47% | 12.64% | 0.38% | 0.26% | 0.32% | 0.44% | 0.62% | 0.60% | 32.55% | 0.58% |
Drawdowns
WST vs. DHR - Drawdown Comparison
The maximum WST drawdown since its inception was -59.29%, which is greater than DHR's maximum drawdown of -45.80%. Use the drawdown chart below to compare losses from any high point for WST and DHR.
Loading graphics...
Drawdown Indicators
| WST | DHR | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -59.29% | -45.80% | -13.49% |
Max Drawdown (1Y)Largest decline over 1 year | -24.70% | -24.85% | +0.15% |
Max Drawdown (5Y)Largest decline over 5 years | -59.29% | -39.81% | -19.48% |
Max Drawdown (10Y)Largest decline over 10 years | -59.29% | -39.81% | -19.48% |
Current DrawdownCurrent decline from peak | -46.22% | -34.20% | -12.02% |
Average DrawdownAverage peak-to-trough decline | -16.79% | -10.08% | -6.71% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 12.05% | 8.34% | +3.71% |
Volatility
WST vs. DHR - Volatility Comparison
West Pharmaceutical Services, Inc. (WST) and Danaher Corporation (DHR) have volatilities of 9.11% and 8.93%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| WST | DHR | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.11% | 8.93% | +0.18% |
Volatility (6M)Calculated over the trailing 6-month period | 24.91% | 20.17% | +4.74% |
Volatility (1Y)Calculated over the trailing 1-year period | 41.43% | 32.45% | +8.98% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 40.04% | 27.75% | +12.29% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 34.28% | 25.24% | +9.04% |
Financials
WST vs. DHR - Financials Comparison
This section allows you to compare key financial metrics between West Pharmaceutical Services, Inc. and Danaher Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
WST vs. DHR - Profitability Comparison
WST - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, West Pharmaceutical Services, Inc. reported a gross profit of 303.90M and revenue of 805.00M. Therefore, the gross margin over that period was 37.8%.
DHR - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Danaher Corporation reported a gross profit of 3.97B and revenue of 6.84B. Therefore, the gross margin over that period was 58.0%.
WST - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, West Pharmaceutical Services, Inc. reported an operating income of 157.10M and revenue of 805.00M, resulting in an operating margin of 19.5%.
DHR - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Danaher Corporation reported an operating income of 1.50B and revenue of 6.84B, resulting in an operating margin of 22.0%.
WST - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, West Pharmaceutical Services, Inc. reported a net income of 132.10M and revenue of 805.00M, resulting in a net margin of 16.4%.
DHR - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Danaher Corporation reported a net income of 1.20B and revenue of 6.84B, resulting in a net margin of 17.5%.